The Nanomedicine Workshop offers a unique and engaging forum for medical professionals, scientists, engineers, and industry stakeholders from various fields, to acquire up-to-date knowledge on Nanomedicine advancements related to Biomedical Engineering, Biomedicine, Nanomaterials and Clinical Applications. It aims to offer a forum for academia and industry around the world, to network across the ecosystem, to foster partnerships and showcase state-of-the-art scientific and technological advancements in Nanomedicine.

The workshop provides participants the opportunity to gain valuable insights from invited keynote speakers who possess expert knowledge on worldwide innovation trends and the science of nanomedicine, thereby facilitating the convergence of Nanosciences-Nanotechnologies with clinical practice. The scientific program will include comprehensive talks, special sessions, debates, oral and poster presentations of peer-reviewed contributions, that highlights the most recent breakthroughs in various fields of Nanomedicine.

The Workshop will address progress and prospects for nanomedicine including, Nanotoxicology, Biomedical Engineering, Nanobiotechnology, Pharmaceutical Nanotechnology, Nanoparticles and Molecular Nanotechnology, Regenerative Medicine, Cancer Nanomedicine, updates on Preclinical & Clinical Trials and Regulations.

Together with the co-located Bioelectronics Workshop, it will provide the latest advances in biosensors and bioactuators from bench to bedside. Fundamentals of biosensor design and manufacturing will be covered and translated into clinical applications.

The Nanomedicine Workshop covers (but not limited to) the following key topics:

Basics related to Medicine, Biology, and Nanotechnology

  • Biological Systems and Biological Structures
  • Biomedical Engineering & Nanobiotechnology
  • Nanotechnology for Health products
  • Cell/Nanomaterial Interactions & Cellular-Level Interventions
  • Biomechanics


  • Theranostics
  • Nanotoxicology
  • Nanoinformatics
  • Clinical Nanomedicine
  • Nanovaccines and Immunotherapy
  • Nanomedicine-based cancer immunotherapy
  • Stimuli-responsive nanosystems

Nanomaterials for Bio-Applications

  • Nanostructures for medical applications
  • Biomaterials and Bio-Nano Interface
  • Nanoparticles & Nanosystems for Health care

Clinical Applications

  • Biomaterials and Nanomaterials for biosensing, imaging, diagnostic and vectorization
  • In-vivo Diagnostics, Imaging & Therapy
  • Nanosurgery: Precision Instruments & Nanorobotics
  • Drug Delivery Systems (DDS)
  • Tissue engineering & Regenerative Nanomedicine
  • Nanoparticles and Molecular Nanotechnology
  • Nanodrugs and Pharmaceutical Nanotechnology
  • Nano-Cosmetics
  • Nanodentistry
  • Nanomedicine Targeting Major and Chronic Diseases
  • Clinical Translation and Regulations

Update on Preclinical and Clinical trials on Nanomedicine

Nanotoxicity, Risk Assessment and Ethics

Commercialization in Nanomedicine

Special Session on Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases (Bio2Brain MSCA Project)


The Special Session on Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases will promote the research and training activities of the Bio2Brain Marie Skłodowska-Curie EU Project. Bio2Brain provides a unique opportunity for 13 early stage researchers (ESRs) to pioneer new paradigms and treatments for neurological diseases and will establish the foundation for the future transfer of the developed technologies for subsequent clinical development and GMP manufacturing.

During the Special Session 13 individual research projects will be presented:

  • Project 1 – Particle-based formulations for the intransal transmucosal delivery of Biopharmaceuticals
  • Project 2 – Bio-based hydrogels as drug delivery systems for the intranasal transmucosal delivery of Biopharmaceuticals
  • Project 3 – (Bio)polymer-based particulate formulations for the intranasal transmucosal delivery of Biopharmaceuticals
  • Project 4 – Analysis of mAb transport and its dependency on Fc-interacting molecules in vitro, ex vivo and in vivo
  • Project 5 – Safe-by-Design
  • Project 6 – Nose to Brain application of wildtype and engineered antibodies in the pathophysiological context in vivo
  • Project 7 – Advanced imaging approaches for dissecting the mechanisms of release and trafficking of Biopharmaceuticals
  • Project 8 – A computational approach to optimal design of DDS
  • Project 9 – Development of new polymeric nanogels as drug delivery systems
  • Project 10 – Development of new micro-polymers for intranasal drug delivery: study of interfacial behaviour with biological membranes
  • Project 11 – Rational design of a panel of antibodies targeting Nogo-A
  • Project 12 – Rational design of a panel of antibodies targeting LINGO-1
  • Project 13 – Hyaluronan based hydrogels for mucosal drug delivery

Special Session on Smart, Multifunctional Dental Implants (I-SMarD EU Project)


The Special Session on Smart, Multifunctional Dental Implants is supported by the EU-Funded Project I-SMarD (link) that aims to promote the sustainable development of the next generation dental implants, using advanced manufacturing techniques and novel nanomaterials. During the Special Session the topics that will be discussed are:

  1. Delivery of “smart”, multifunctional titanium implants which:
    1. can detect the changes in the surrounding microenvironment and respond by releasing agents to prevent bacterial colonisation;
    2. will have the appropriate structure to match the anatomical characteristics of dental tissues and the components to promote the formation of implant/bone and implant/soft tissue interfaces,
  2. Utillise additive manufacturing techniques aiming to promote near-patient manufacturing towards increased functionality and personalisation of our dental implants,
  3. Achieve cost optimization of the different materials and fabrication procedures in order to deliver an effective medical device,
  4. Deliver technologies and tools that can benefit the development, design and evaluation of medical devices, such as Finite Element models for biomechanical analysis of the dental implants and optofluidic bioreactors that will be an intermediate evaluation step between in vitro testing and animal trials.



V. Karagkiozaki (Chair), Dep. of Physics, Aristotle University of Thessaloniki and Lifestyle Medicine Clinic, Greece
T. Mitsiadis (co-Chair), Uni of Zurich, Switzerland
N. Baldini, Uni of Bologna and Istituto Ortopedico Rizzoli, Italy
M. Buehler, Massachusetts Institute of Technology, USA
L. P. Balogh, Precision Nanomedicine, USA
E. Chang, Dept of Oncology, Lombardi Comprehensive Cancer Center, Georgetown Uni, USA
Th. Choli – Papadopoulou, Chemistry Dept, AUTh, Greece
H. Hosseinkhani, Innovation Center for Advanced Technology, Matrix, Inc., USA
J. R. Kanwar, All India Institute of Medical Sciences Bhopal, India
G. Kousoulas, Division of Biotechnology & Molecular Medicine, Louisiana State Uni, USA
M. Masserini, Medical School- Uni of Milan Bicocca, Italy
H. J. Meisel, Department of Neurosurgery, BG-Clinic Bergmannstrost, Germany
A. Mikos, Rice Uni, USA
Y. Missirlis, Lab of Biomechanics & Biomedical Engineering, Uni of Patras, Greece
D. Paolino, University "Magna Graecia" of Catanzaro, Italy
M. Stevens, Imperial College London, UK
S. Sunoqrot, Al-Zaytoonah University, Jordan
M. Tanaka, Kyushu Uni & Uni of Yamagata, Japan

Organized by:

ff2s logo EU H2020-FlexFunction2Sustain: "Open Innovation Ecosystem for Sustainable Nano-functionalized Flexible Plastic and Paper Surfaces and Membranes"

Supported by:

nanonet logo gr nanomed logo


Disclaimer and Scam Information:
The NANOTEXNOLOGY 2024 Organizing Committee has been informed that third-party companies, pretending to be acting on behalf of the Organizers, have contacted the event speakers and attendees via telephone calls and emails requesting information for the payment of their registration fees and/or their accommodation.
We kindly ask you to DISREGARD these messages and to NOT proceed to any arrangement or payment to these third-party companies, because they do not represent in any way the Organizers.
The Organizers have not authorized any third-party entity to contact participants, attendees or exhibitors, regarding their registration and accommodation nor to distribute or sell attendees lists related to NANOTEXNOLOGY events. Please trust only the information and instructions at the Official NANOTEXNOLOGY 2024 website and the messages you receive only by the Organizing Committee. In case you receive a suspicious call or email, we kindly ask you to inform us.
Under no circumstances shall the Organizers be held liable or responsible for any claims, losses, damages, expenses or other inconvenience resulting from the actions of these third-party companies.


Signup for our newsletter and stay informed with latest NANOTEXNOLOGY news!

Please read our privacy policy.


NN is Organized by

ltfnauth_logo cope-nano flex2energy realnano logo ff2s logomusicode logonanomecommons logosmartline logocornet logo physicsnn pgc logonanonethope-a

NN is Supported by

ECh2020 logoUCBerkeley-text-logologo U2BX1PRAXI.logoalex innov zoneportopalace logo

Under the Auspices of

physics auth logo